Becton Dickinson Exposure Increased

  I last reviewed Becton Dickinson (BDX) in this August 6, 2024 post at which time I thought the company was on the path to improved returns; BDX had recently released its Q3 and YTD2024 results and revised FY2024 guidance and announced its plan to acquire Edwards Lifesciences' Critical Care Product Group. On September 3, [...]

Danaher Exposure Further Increased

I am currently re-reading Richer, Wiser, Happier How the World's Greatest Investors Win in Markets and Life by William Green, a book listed in the Books section of this blog. Over the years, the author interviewed many of the world's prominent investors. They spoke candidly about their setbacks and challenges and shared the most valuable [...]

Dividends Have Drawbacks

Dividends can be a great way to return value to shareholders. They do, however, have drawbacks. Do NOT fixate on dividend metrics. Instead, analyze how companies allocate their capital. They can: reinvest in the business; debt reduction; merge or acquire other businesses; distribute dividends; and/or repurchase shares. Typically, companies employ one or more of the [...]

Nike Exposure Increased

  Nike (NKE) releases its Q2 and YTD 2025 results on December 19 at which time I intend to revisit this existing holding. The purpose of this brief post, therefore, is merely to disclose that my NKE exposure increased on December 3 with the purchase of 200 shares @ $78.4769 through a 'Core' account within [...]

FFJ Portfolio – November 2024

Another month has flown by thus triggering this FFJ Portfolio - November 2024 report; all monthly reports are accessible here. I deployed only ~$94,793 USD during the month and reinvested minimal dividend income. The value of the FFJ Portfolio, however, increased ~$ 35,427 CDN and  ~$ 440,440 USD in one month. None of my existing [...]

Go to Top